CRISPR Used to Reverse Blood Disorder Symptoms

CRISPR Used to Reverse Blood Disorder Symptoms

In a paper published in the July 31 issue of Science Translational Medicine, researchers at Fred Hutchinson Cancer Research Center used CRISPR-Cas9 to edit long-lived blood stem cells to reverse the clinical symptoms observed with several blood disorders, including sickle cell disease and beta-thalassemia.

Read Full Article »
Comment
Show comments Hide Comments

Related Articles